Patents by Inventor Alexander McLellan

Alexander McLellan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230210591
    Abstract: Temperature sensing catheters and systems that can be used during cardiac ablation procedures to measure and monitor temperatures, and the rate and spread of temperature changes in the heart. The temperature data can be used to calculate temperature gradients, which may be used to estimate if and when certain regions of heart may undergo injury due to thermal exposure. The temperature data can be used to limit or cut-off power delivery to an ablation catheter, or otherwise modify the ablation procedure, to prevent injury to certain regions of heart. In some cases, the temperature data is used to control aspects of the ablation in a feedback loop control scheme.
    Type: Application
    Filed: April 21, 2021
    Publication date: July 6, 2023
    Inventors: Alexander MCLELLAN, Elli TUTUNGI, Matthew HALLAM, Vicki TUTUNGI
  • Publication number: 20210085993
    Abstract: An oral hygiene device comprises a housing having an outside mouth portion and an inside mouth portion, at least one energy delivery element disposed in or on the inside mouth portion, configured to deliver energy to one or more teeth of a subject, a controller disposed in the outside mouth portion electrically connected to the at least one energy delivery element, an energy storage unit disposed in the outside mouth portion, and a sleeve removably connected to the inside mouth portion of the housing, the sleeve having upper and lower channels configured to accept the upper and lower teeth of the subject. A method of using an oral hygiene device and a method of administering an oral hygiene treatment are also described.
    Type: Application
    Filed: September 21, 2020
    Publication date: March 25, 2021
    Inventors: Mark Tullio Morreale, Martin Labrecque, Sherri McFarland, Colin G. Cameron, Martin Greenwood, S. Alexander McLellan, Christopher David Gillespie
  • Publication number: 20180207110
    Abstract: The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing terpene compounds isolated from plant essential oils or manufactured synthetically is detailed. These compounds, such as geraniol and citronellol, as well as chemical analogs thereof, used in combination or individually, can be used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 26, 2018
    Inventors: Alexander McLellan, Frank Greenway
  • Patent number: 9999601
    Abstract: The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing terpene compounds isolated from plant essential oils or manufactured synthetically is detailed. These compounds, such as geraniol and citronellol, as well as chemical analogs thereof, used in combination or individually, can be used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: June 19, 2018
    Assignee: NEUROQUEST INC.
    Inventors: Alexander McLellan, Frank Greenway
  • Publication number: 20180055903
    Abstract: The present invention provides a method of treating neuropathic pain by administering a topical homeopathic composition to a mammalian subject. The homeopathic formulation contains homeopathic active ingredients comprising Hypericum perforatum in a base of essential oils which facilitate delivery of the homeopathic ingredient through the skin.
    Type: Application
    Filed: April 6, 2017
    Publication date: March 1, 2018
    Inventor: Alexander MCLELLAN
  • Publication number: 20170136081
    Abstract: The present invention provides a therapeutically effective composition and method of treatment of neuropathic pain utilizing extracts of Monarda, for example, Monarda fistulosa and related species, used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.
    Type: Application
    Filed: January 27, 2017
    Publication date: May 18, 2017
    Inventor: Alexander McLellan
  • Publication number: 20160317466
    Abstract: Compositions comprising terpene compounds for the treatment of negative sensory phenomena (NSP). Negative sensory phenomena is characterized by a decreased ability to sense light touch, pin prick, vibration, temperature, pain and/or reduced proprioception. The terpene compounds are preferably aromatic terpene compounds such as geraniol and citronellol and analogs thereof. The terpenes may also be used in combination. The terpenes are derived form plant essential oils or are manufactured synthetically.
    Type: Application
    Filed: July 12, 2016
    Publication date: November 3, 2016
    Inventors: Alexander McLellan, Frank Greenway
  • Patent number: 9415023
    Abstract: Compositions comprising terpene compounds for the treatment of negative sensory phenomena (NSP). Negative sensory phenomena is characterized by a decreased ability to sense light touch, pin prick, vibration, temperature, pain and/or reduced proprioception. The terpene compounds are preferably aromatic terpene compounds such as geraniol and citronellol and analogs thereof. The terpenes may also be used in combination. The terpenes are derived form plant essential oils or are manufactured synthetically.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: August 16, 2016
    Assignees: NeuroQuest Inc., Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Pennington Biomedical Research Center
    Inventors: Alexander McLellan, Frank Greenway
  • Publication number: 20150374773
    Abstract: The present invention provides a method of treating neuropathic pain by administering a topical homeopathic composition to a mammalian subject. The homeopathic formulation contains homeopathic active ingredients comprising Hypericum perforatum in a base of essential oils which facilitate delivery of the homeopathic ingredient through the skin.
    Type: Application
    Filed: September 10, 2015
    Publication date: December 31, 2015
    Inventor: Alexander MCLELLAN
  • Publication number: 20140357725
    Abstract: The present application provides terpene analogues of Formula 1 and methods and uses thereof for treating neurological conditions such as pain in general and neuropathic pain specifically. wherein: Y is a C1 to C20 alkylene, C?O, SO, SO2, or absent; X is H, OR1, N—(R2)2, a C1 to C20 alkyl, or a heterocyclyl (for example, heteroaryl), wherein when Y is absent X is not H; R1 is H, a C1 to C20 alkyl, or a CH2-aryl; R2 is independently H, a C1 to C20 alkyl, aryl, OR1, CN or C(?O)—R3; R3 is a substituted or unsubstituted C1 to C20 alkyl, or a aryl; W is H, C1 to C20 alkyl, or aryl; and Z is C1 to C20 alkylene; or a pharmaceutically acceptable isomer, salt or ester thereof. These terpene analogues are useful in treating pain and can also be used to treat other electrical disorders in the central and peripheral nervous system.
    Type: Application
    Filed: July 13, 2012
    Publication date: December 4, 2014
    Applicant: NEUROQUEST INC.
    Inventors: Donald F. Weaver, Mark Andrew Reed, Alexander McLellan, Shengguo Sun
  • Publication number: 20130267571
    Abstract: The present application provides a terpene analogue of Formula (I) or a pharmaceutically acceptable isomer, salt or ester thereof, and methods and uses thereof for treating neurological conditions such as pain in general and neuropathic pain. These terpene analogues can also be used to treat other electrical disorders in the central and peripheral nervous system. Also provided are methods of synthesizing the terpene analogues of Formula I.
    Type: Application
    Filed: September 14, 2011
    Publication date: October 10, 2013
    Applicant: NeuroQuest Inc.
    Inventors: Mark A. Reed, Donald Weaver, Shengguo Sun, Alexander McLellan, Erhu Lu
  • Publication number: 20120308674
    Abstract: The present invention provides a therapeutically effective composition and method of treatment of neuropathic pain utilizing extracts of Monarda, for example, Monarda fistulosa and related species, used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.
    Type: Application
    Filed: February 1, 2011
    Publication date: December 6, 2012
    Applicant: ORIGIN BIOMED, INC.
    Inventor: Alexander McLellan
  • Publication number: 20120128787
    Abstract: The present invention provides a method of treating neuropathic pain by administering a topical homeopathic composition to a mammalian subject. The homeopathic formulation contains homeopathic active ingredients comprising Hypericum perforatum in a base of essential oils which facilitate delivery of the homeopathic ingredient through the skin.
    Type: Application
    Filed: November 18, 2009
    Publication date: May 24, 2012
    Applicant: ORIGIN BIOMED INC.
    Inventor: Alexander Mclellan
  • Publication number: 20110257255
    Abstract: The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing terpene compounds isolated from plant essential oils or manufactured synthetically is detailed. These compounds, such as geraniol and citronellol, as well as chemical analogs thereof, used in combination or individually, can be used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.
    Type: Application
    Filed: August 6, 2009
    Publication date: October 20, 2011
    Inventors: Alexander McLellan, Frank Greenway
  • Publication number: 20110144191
    Abstract: Compositions comprising terpene compounds for the treatment of negative sensory phenomena (NSP). Negative sensory phenomena is characterized by a decreased ability to sense light touch, pin prick, vibration, temperature, pain and/or reduced proprioception. The terpene compounds are preferably aromatic terpene compounds such as geraniol and citronellol and analogs thereof. The terpenes may also be used in combination. The terpenes are derived form plant essential oils or are manufactured synthetically.
    Type: Application
    Filed: August 13, 2009
    Publication date: June 16, 2011
    Inventors: Alexander McLellan, Frank Greenway
  • Patent number: D932023
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: September 28, 2021
    Assignee: PhotoDynamic Inc.
    Inventors: Mark Tullio Morreale, Sherri McFarland, Colin G. Cameron, Martin Greenwood, S. Alexander McLellan